Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
component pertussis-diphtheria-tetanus vaccine
- Development stage
- Preclinical
- Lead developer
- Zhifei Biological
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The component pertussis-diphtheria-tetanus vaccine (Component DPT) is a trivalent subunit vaccine developed by the Chongqing Institute of Biological Products, a subsidiary of Zhifei. It is designed to prevent three major infectious diseases: pertussis (whooping cough), diphtheria, and tetanus. The vaccine is manufactured by purifying and detoxifying specific antigens of *Bordetella pertussis*, including pertussis toxin, which are then blended with diphtheria and tetanus toxoids and formulated with an aluminum adjuvant. This component-based approach is intended to elicit protective antibody responses against the toxins and bacterial antigens of *Bordetella pertussis*, *Corynebacterium diphtheriae*, and *Clostridium tetani*, potentially offering a more refined safety profile compared to whole-cell vaccines.
- Other names
- Component DPTComponent Pertussis-Diphtheria-Tetanus Vaccinepertussis + diphtheria + tetanus vaccine-Chongqing Institute of Biological Products-Pertussis toxin-Bordetella pertussis antigens-Diphtheria toxoid-Tetanus toxoid-component/subunit vaccine-Pertussis-Diphtheria-Tetanus
02
Targets
TT (Tetanus toxoid)
Beyond the preview
Go deeper on component pertussis-diphtheria-tetanus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on component pertussis-diphtheria-tetanus vaccine.